ML20214H857
| ML20214H857 | |
| Person / Time | |
|---|---|
| Site: | 03013426 |
| Issue date: | 09/24/1986 |
| From: | Riedlinger B NRC OFFICE OF INSPECTION & ENFORCEMENT (IE REGION V) |
| To: | |
| Shared Package | |
| ML20214H860 | List: |
| References | |
| 50-17838-01, 50-17838-1, NUDOCS 8612010065 | |
| Download: ML20214H857 (5) | |
See also: IR 05000178/2038001
Text
{{#Wiki_filter:-_-- _ _ _ _ _ - _ _ _ _ _ _ m m ---- --- mm mmmmmm - - - mmm mm m mmcac4kummm m m mm m mm m mm mm mm mm mmm my NRC Faem 374 e 1 5 g PAGE OF PAGES (3-83) U.S. NUCLEAR REGULATORY CoMMISSloN Amendment No. 18 N MATERIALS LICENSE f Pursuant to the Atomic Energy Act of 1954, as amended, the Energy Reorganization Act of 1974 (Public Law 93-438), and Title 10, Code of Federal Regulations, Chapter 1, Parts 30,31,32,33,34,35,40 and 70, and in reliance on statements and representations y heretofore made by the licensee, a license is hereby issued authorizing the licensee to receive, acquire, possess, and transfer byproduct, y source, and special nuclear material designated below; to use such material for the purpose (s) and at the place (s) designated below;to i deliver or transfer such material to persons authorized to receive it in accordance with the regulations of the applicable Part(s). This ji license shall be deemed to contain the conditions specified in Section 183 of the Atomic Energy Act of 1954, as amended, and is jE subject to all applicable rules, regulations and orders of the Nuclear Regulatory Commission now or hereafter in effect and to any conditions specified below. g f Licensee In accordance with letter
- l
dated July 28, 1986 ju itsentiretytoreadasfollows:j 1. Providence Hospital 3. License number 50-17838-01 is amended in Radiation Safety Office j - - ll '. 2. 3200 Providence Drive; Pouch 6604, C i , , Anchorage, Alaska 99502 s '.f * * 4. Expiration date August 31, 1988 i ..s, , - l
- '
' 30-13426 l N eren No. 6. Byproduct, source, and/or 7. Chemical and/or physical (8. Maximum amount that licensee I special nuclear material N form < imay possess at any one time I 'u N / A. nder this license ~ As necessary for uses N ,a , - A. Any byproduct material A. -jAny radiopharmaceutical. listed in Groups I and ~ < listed in Groups L and'II . authorized in i ' - I JSubitem 9.A. I II of Schedule A,'T of; Schedule'A,i Sectionf t ~ Section 35.100 of - 35.'100 of.'10 CFR 35 - ' ")
10 CFR 35 'I );-
Z p ,t ca. y . ,
- -
, , , B. Any byproduct material , B .' ' Any -form' listed in; Group IIL B. ;'3 curies of each N l listed in Group III' . of Schedule'A,.Section-35.100 fbyproductmaterial I 'S of 10 CFR 35; p _ l'; authorized in l of Schedule A, e Section 35.100 of 10'CFR 35 t ' g " Subitem 6.B. y . 4 s j, y' ' n. f g , . , (, C; As necessary for uses i C. Any byproduct material' C. Any radiopharmaceutical ' f , Schedule A,'Section 35.100 [V ' 'j listed in! Group IV ofJ authorized in i listed in Group IV Subitem 9.C. I of Schedule A, l Section 35.100 of 10 CFR 35j of 10 CFR 35 , , . D. Any byproduct material D. Any radiopharmaceutical D. As necessary for uses y listed in Group V listed in Group'V of authorized in y of Schedule A, Schedule A, Section 35.100 Subitem 9.D. N Section 35.100 of 10 CFR 35 of 10 CFR 35 E N N E. Any byproduct material E. Any sealed source listed E. 2 curies total g listed in Group VI of in Group VI of Schedule A, for all sources y Schedule A, Section Section 35.100 of 10 CFR 35 authorized in N 35.100 of 10 CFR 35 Subitem 6.E. N N l F. Strontium 90 F. Sealed source (Nuclear F. 10 mil 11 curies Enterprises reference p l source No. 2503/3) p p G. Cesium 137 G. Sealed source (J.L. Shepherd G. 100 millicuries
- W
and Associates Instrument jE E Calibrator Model 28-5) s\\ l H. pleted uranita H. Cadmium plated metal H. 110 kilograms
f7 N*"#NA -01 PDR
-7--------------------------mmacm---==------______--__y RC Earm 374A U.S. NUCLEAR REGULATORY COMMISSION 2 5 i PACE og paces License number l l 50-17838-01 MATERIALS LICENSE
- *" * * *
SUPPLEMENTARY SHEET l
030-13426 y > Amendment No. 18 l l N l 6. BYPRODUCT, SOURCE, AND/0R 7. CHEMICAL AND/0R PHYSICAL 8. MAXIMUM AMOUNT THAT LICENSEE SPECIAL NUGLEAR MATERIAL FORM MAY POSSESS AT AhY ONE TIME UNDER THIS LICENSE N 1. Gadolinium 153 I. Sealed sources I. Not to exceed l (Lunar GD Series) 1.5 curies per source l, 9. Authorized use g m n y~ n l A. Any diagnostic procedure listed in Groups 'IgandiII of Schedule A, Section 35.100 l " V [y,f N of Title 10, Code of Federal, Regulations. l ry B. Preparation and use of.r'ad16 pharmaceuticals for any diagnostic procedure listed i in Group III of Schedule"A, Section 35.100 of Title 10, Code of Federal y Regulations. Y ~/^ p y Q / f .";, p < C. Any therapeutic prodedure' list'ed.in Group IV of Schedule A, Section 35.100 of i ~ _ // ' E Title 10, Code of, Federal Regulat' ions. ' m C f_ l, ? N l% ~ f. e ' ' g I D. Any therapeutic procedure listed in Grous Vlof Schedule A, Section 35.100 of g Title 10, Code of~ Federal Regulations. ' u d ,,) ; ~ p _ V < l ~.. (L ' ~ , , E. Any procedure listed in ' Group VI .of. Schedule: A,d Sectionl5.100 hf[ Title 10, code E E " /
- T
of Federal Regula't' ions. O " a , -! J t
- k~
g3 y; [ f ( e 3 p l Q, 7 [[ l v; - ' ' F. and G. Instrument calibration.t; y , , d,_" . > Ar, p o - _ . . 3 , H. Asshieldinginalinear,accblerator.. ,[ lN / ,. y, N ,. 3 - t. . - f,s tl - - s 1 , g I. For use in a Lunar Radiation Corporation Model DP3 bone l mineral analyzers for g diagnostic studies. \\" g . F b CONDITION,S." e . - , 10. Licensed material shall be used only at Providence Hospital, 3200 Providence E Drive, Anchorage, Alaska, except that licensed material described in License l Conditions 6.I, 7.I., 8.I., and 9.I. may also be used in Room 2 of the y, Providence Professional Building, 3300 Providence Drive, Anchorage, Alaska. g 5 11. Licensed material listed in Item 6 above is authorized for use by, or under the E supervision of, the following individual (s) for the materials and uses E l indicated: 5 Maurice J. Coyle, M.D. Groups I, II, III and VI $ Iodine 131 contained in capsules for p treatment of hyperthyroidism and N cardiac dysfunction E j! Gadolinium 153 'n i 8 1il wwwr-w--#=r-wme.c=r 060ssmw ymr#,r- d
w - - - - m m m m m m m.;m m m m - - - m - m _ ,- - - - - - -i RC Form 374A U.S. NUCLEAR REtULATORY COMM!SSt!N 3 5 l ' pace op paces License number l l MATERIALS LICENSE 50-17838-01
- ' ' * " ' * " " "
SUPPLEMENTARY SHEET l ' 030-13426 y I Amendment No. 18 II E l CONDITIONS N (continued) y 1 John J. Kottra, M.,D. .. Groups I, II and III _ . Iodine 131 contained in capsules for y treatment of hyperthyroidism and y cardiac dysfunction g Gadolinium 153 p .g S6. d. It C G / y _ E , O Groups IV, V and,VI , N Charles Sternhagen, M.D. , y/ ( M1q l PeterDeMottSwift,M.D.N[; Group VI /"
y ,w f x v) i Darwin L. Zellmer, PhlD. Non-human use <Q p . . _ _ _ . ._ _ _ . o Groups I, II and1III:: '. ll n <N ,- l ' Denise 0. Co_ok , M D.;.'.'.d y N .g . p /~ " [ ; ] treatment of;hyperthyroidis( and l ' / cardiac l dysfunction (j g
- .g
s w - 1 5 Gadolinium 153; , p 2 _
- ..
(L _fM W n: ?, c: y E 'Ghoups I,d Iland III M [ E 2 David Allen Moeller, M.D( ;; ' n4 Iodine l131? contained in capsules for E "" 7 ') j ftredtmedt$ofhyperthyroidism, cardiac ! g% "' 4 j dysfunction;.or' thyroid carcinoma p O' i ', ' . Colloidalsphosphorus 32 for- E V', ~ h (intraca' itary treatmenti9 1 - v 1. ' ,, ,4 ^ ' N ' ' Gadolinium *153 V' 5 < 3 ' Kenneth Allen Fox, M.D. Group VI h ' 4 4 . . , 12. For a period not to exceed sixty *(60); days ~in a'ny ' calendar year, a visiting h physician is authorized to use ifcensed material for human use under the terms E of this license, provided the visiting physician: l N A. Has the prior written permission of the hospital's Administrator and its g Radiation Safety Committee, and $ 1 B. Is specifically named as a user on a Nuclear Regulatory Commission licen.se N authorizing human use, and li C. Performs only those procc.dures which the physician is specifically y authorized to perform pursuant to a license issued by the Nuclear p Regulatory Commission. 5 5 The licensee shall maintain for inspection by the Commission copies of the l written permission specified in A. above and of the license (s) specified in B. g and C. above for a period of 5 years from the date permission is granted under p A. above, p I ip <-r-awnwar#wansremw + m rr.ner- - - - s.'I. . _ . . _ __ -- - ,-_ - - - _ - -
_----.-*-.....m.-----
_% m gnC Form 374A U.S. NUCLEAR REGULATORY CoMMISSCN 4 5 l pace og ,,aes License number l 50-17838-01 MATERIALS LICENSE
- ' ' * " ' * * "
SUPPLEMENTARY SHEET l 030-13426 y l Amendment No. 18 l l l l CONDITIONS i (continued) g i 13. Patients containing iodine 131 for the treatment of thyroid carcinoma I (or patients containing therapeutic quantities of gold 198) shall remain I hospitalized until the residual activity is 30 m1111 curies or less. f i 14. Sealed sources containing licensed materia 14shall not be opened. l p, d E~~ G R Thesource(s)specif1ed@inItem(s)7.$.'/>,., - 5 15. A. (1) 7;F., and 7.G. shall be i , tested for leakaje and/or contamination at' intervals not to exceed 6 I months, excepth that Series 6500 or 6520 (formerly_Model 6D6C) Minnesota l Mining and Manufacturing Cesium 137 sources shall be tested at intervals y not to exceed"three years. The source (s) specifiEdlin Item 7.I. ~ l shall be , tested.for_ leakage and/or contamination at" intervals not to ill exceedon'dryear.iAay'sourcereceivedfrom(anotherpersonwhichisnot I accompanied by a certificate indicating that a test was performed I ' ~ f within 6 months before .tlie transfer shall'not be put into use until t [ h=L } l ~ ' C) g ,' l \\
tested.g
L \\ , .. > . , (2) Notwithstanding 'the periodic leak test"regiaired by thif condition, Lf N licensed ' scaled source,is exempt from such leak testsTwhen the source i ^ materia 1 or 10 microduries "oriledsj o[ bet'a and/or* gamma: emitting l contains100 microcuries'or less of 7 f alpha emitting. material. p 9
, g3 ; wqua;_ 3 p Any source in 'torage and not being'usid nssd not be tested. When the g B. s source is removed"from stordge fo'r.useJor transfer to another person, it P ' shall be tested before use or transfer.1 .] ' - % ,,\\y C. The test shall be capable of. detecting the presence"of 0.005 microcurie of ! radioactive material on the' tent sample., Iffthe test reveals the presence gl of 0.005 microcurie or more of removable, contamination, the source shall be h ~ removed from service and decontaminat'ed, repaired, or disposed of in E accordance with Commission regulations. A report shall be filed within 5 l days of the date the leak test result is known with the U. S. Nuclear y Regulatory Commission, Region V; Nuclear Materials Safety and Safeguards g Branch; 1450 Maria Lane, Suite 210; Walnut Creek, California 94596. The g report shall specify the source involved, the test results, and corrective I action taken. Records of leak test results shall be kept in units of I microcuries and shall be maintained for inspection by the Commission. l Records may be disposed of following Commission inspection. y b D. Tests for leakage and/or contamination shall be performed by the licensee p or by other persons specifically licensed by the Commission or an Agreement f)B Stste to perform such services. n i R il
- f
- M
m wrve.- m .v.%+,w w m g g
- ,g,77,.n r,.rirM5
r _ _ _ . _ ._ _ ._. .
raruu-amm-----------mm-
9 RC Porm 37M U.S. NUCLEAR REtOLAToRY CoMMISSl!N N PAGE OF PACES License number l ' 50-17838-01 i MATERIALS LICENSE g
- ' ' * " * * " " "
030-13426 l SUPPLEMENTARY SHEET l f _ Amendme.nt No. 18 y )(continued) CONU m 0hs N , N 16. The licensee is authorized to hold radioactive material with a physical l
half-life of less than 65 days for decay-in-storage before disposal in ordinary y trash provided: g l A. Radioactive waste to be disposed of in this manner shall be held for decay B . a minimum of ten (10) half-lives. II B. Prior to disposal as normal waste, radioactive waste shall be surveyed to l determine that its radioactivity cannot be _ distinguished from background. y All radiation labels shall.be removedior obliteraten. p y. - v gg y C. Generator columns shall,be segregated so that they:may be monitored I separately to ensurendecay to background levels prior'to disposal. l .> p ,. - g 17. The licensee may use the' Lineator device for doing linearity, tests of its dose y calibrator provided,1,t follows the procedures in the Atomic Products Corporation .g Lineator Instructions Manual. dated June 20, 1983. <,.e p a- i M/ A43s ,' y , , , , , ll
18 Except as specifically providediotherwise(in;thjs license, the licensee shall conduct its program in accordance with the' statements,lrepresentations, and 3 procedures contained in the documents including any; enclosures, listed below. p The Nuclear Regulatory Commission's legulatiiins7shall' govern unless the statements, p ~^ representations and procedures in the' licensee's application andf correspondence i are more restrictive than the reg'lations'.? jp# ? E T ' ' u < g% _. , . s "u s t,. <3 ~z % i - - < e' ' p ,i _~g, A. Application dated'Novemberf30,<1982; l k +? c.f, g , , B. Application dated February'21,~19834 1 / h "' ' M/ p C. Letter dated July (13, 1983 b 6 pu , , , < ~ N I D. Letter dated August /17,1983 q .i p' ?. E. Letter dated January 20,s1984 ,- V N ~ F. Letter dated February 13, 1984 f , G. Telegram dated February 22,'1984 p
' H. Letter dated March 6, 1984 < , I. Letter dated May 15, 1986 p J. Letter dated July 28, 1986 i K. Letter dated September 18, 1986, with attachments E E E' 19. The licensee shall conduct a physical inventory every six (6) months to account g for all sources specified in Item 7.I. which are received and possessed under p the license. Records of the inventories shall be maintained for two (2) years y from the date of each inventory. E I 20. The licensee may transport licensed material in accordance' with the provisions l of 10 CFR Part 71, " Packaging and Transportation of Radioactive Material". g > FOR THE U.S. NUCLEAR REGULATORY COMMISSION l original signed by B. A. Riedlinger 5 Date September 24, 1986 By N I Beth A. Rjedlinger Health Physicist (Licensing) l Nuclear Fbterials Safety Section p Region V = = =oiinwi= = = = w - = = = = memigemawap.7mmmwwTmw -- 2; p - }}